Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?
Clinical trial complexity has significantly increased in the past decade, creating strengthening headwinds in trial duration and cost for developers. But what are the factors behind this phenomenon, and how can the industry adapt and innovate to remain productive?
